Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation

Br J Haematol. 2021 Feb;192(3):667-671. doi: 10.1111/bjh.17258. Epub 2020 Nov 25.

¹ Department of Internal Medicine, University of Texas Health Sciences Center at Houston, Houston, TX, USA.
² Department of Hematopathology, University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA.
³ Department of Leukemia, University of Texas MDACC, Houston, TX, USA.
⁴ Department of Pharmacy, University of Texas MDACC, Houston, TX, USA.
⁵ Departments of Histiocytosis, Leukemia, and Lymphoma, Texas Children's Hospital, Houston, TX, USA.
⁶ Departments of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA.
⁷ Department of Stem Cell Transplantation, University of Texas MDACC, Houston, TX, USA.
⁸ Departments of Lymphoma and Myeloma, University of Texas MDACC, Houston, TX, USA.
⁹ Department of Hematopathology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.

No abstract available

Publication types